Get access

How much diffusion lesion reversal occurs after treatment within three-hours of stroke onset?

Authors

  • Bruce C. V. Campbell,

    Corresponding author
    • Departments of Medicine and Neurology, Melbourne Brain Centre at Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia
    Search for more papers by this author
  • Stephen M. Davis,

    1. Departments of Medicine and Neurology, Melbourne Brain Centre at Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia
    Search for more papers by this author
  • Geoffrey A. Donnan

    1. Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia
    Search for more papers by this author

  • Conflict of interest: The authors declare no potential conflict of interest.

Correspondence: Bruce Campbell*, Department of Neurology, The Royal Melbourne Hospital, Grattan Street, Parkville VIC 3050, Australia.

E-mail: bruce.campbell@mh.org.au

Abstract

In this issue of the journal, Sakamoto et al. present an analysis of diffusion lesion evolution in acute ischemic stroke patients first imaged less than three-hours from stroke onset. Although temporary lesion volume reduction was observed following reperfusion, the affected regions were generally abnormal on follow-up fluid attenuated inversion recovery imaging, indicating lack of tissue salvage. Taken in conjunction with other recent articles, it seems that temporary postreperfusion ‘reversal’ of diffusion lesions is quite common but usually does not translate to permanent tissue salvage. A minority of patients demonstrate permanent reversibility of a component of the acute diffusion lesion. This is dependent on early reperfusion and is more frequent when patients are treated within three-hours. Early reperfusion is clearly associated with a reduction in infarct growth through salvage of ischemic penumbra, and this probably contributes more to the favorable neurological outcomes in these patients than the relatively small volumes of diffusion reversal. It is currently unknown whether future therapeutic advances that increase the speed and success rates of reperfusion will increase the proportion of reversibility further and lead to clinically relevant salvage within the diffusion lesion. For the present, it appears that intravenous tissue plasminogen activator rarely achieves substantial permanent reversal of diffusion lesions, even when administered within three-hours.

Get access to the full text of this article

Ancillary